The next 12 months will be important for the drugmaker.

In early February 2026, WuXi Biologics announced a license and research service agreement granting Vertex Pharmaceuticals ...

Vertex executives warned that Casgevy, its curative treatment for sickle cell disease, would be slow to reach patients. But ...

Vertex Pharmaceuticals is downgraded to Hold ahead of Q4 earnings due to underwhelming growth from key new drugs. Click for ...

The trail enrolled 123 patients at 23 sites across the US and Europe.

If you want to grab a capable and powerful PSU for less, this Woot! deal that takes 42 percent off this 1000W Seasonic Vertex ...

Jupiter Endovascular, Inc. announced completion of patient enrollment in the SPIRARE II pivotal clinical trial evaluating the c ...

Vertex Pharmaceuticals shows improving price performance, earning an upgrade to its IBD Relative Strength Rating ...

What if you'd invested in Vertex Pharmaceuticals (VRTX) ten years ago? It may not have been easy to hold on to VRTX for all that time, but if you did, how much would your investme ...

Jupiter Endovascular announced that it completed patient enrollment in the SPIRARE II pivotal clinical trial evaluating its Vertex system.

Host Tylah Tully looks at Vertex Minerals (ASX:VTX) and the rising gold production coming out of its Reward underground mine in New South Wales as stoping increases and more mining areas are ...